Studies of four Japanese families with hereditary angioneurotic edema: Simultaneous activation of plasma protease systems and exogenous triggering stimuli


Forty-five relatives of 4 families with hereditary angioneurotic edema (HANE) were studied. Twenty-five, including 11 asymptomatic kindreds with the disposition, showed typical changes in complement system compatible with HANE. Follow-up study of HANE patients showed that, even in remission period, complement, coagulation and fibrinolytic systems can be activated. During edema attacks, moderate haemoconcentration and neutrophilia were encountered and kallikrein-kinin system was found to be also activated. Replacement therapy with C \(\bar l\)-inhibitor preparation for an edema attack revealed that clinical improvement paralleled the increase in blood levels of high molecular weight kininogen. Thus, HANE attack is considered to be elicited in kindreds with the hereditary disposition by activation of plasma protease systems, particularly by that of kallikrein-kinin system. On the other hand, exogenous triggers that can initiate activation of the protease systems can be classified into 2, neuro-humoral (sympathetic nerve response) and physico-chemical, categories. Hence, the edema attack of kindreds with the hereditary disposition can at least be modified by the biosynthesis of plasma factors and the individual susceptibility to the liberated catecholamines. These two different reaction processes are considered to be linked by the release of plasminogen activator and/or Hageman factor activating enzyme.

This is a preview of subscription content, log in to check access.


  1. 1.

    Aoki N, Moroi M, Matsuda M, Tachiya K (1977) The behavior of α-2-plasmin inhibitor in fibrinolytic state. J Clin Invest 60: 361–369

    Google Scholar 

  2. 2.

    Blohme G, Ysander L, Korsan-Bengsten L, Laurell AB (1972) Hereditary angioneurotic oedema in three families. Acta Med Scan 191: 209–219

    Google Scholar 

  3. 3.

    Borsos T, Rapp HJ, Mayer MM (1961) Studies on the second component of complement I: The single site mechanism of immune hemolysis and determination of C'2 on a molecular basis. J Immunol 71: 208–210

    Google Scholar 

  4. 4.

    Borsos T, Rapp HJ (1963) Chromatographic separation of the first component of complement and its assay on a molecular basis. J Immunol 91: 851–858

    Google Scholar 

  5. 5.

    Brackertz D (1974) A one year's follow up of treatment of hereditary angioneurotic edema (HAE) with suramin. Allergol Immunopathol (Madr) 11: 163–168

    Google Scholar 

  6. 6.

    Cash JD (1978) Control mechanism of activator release. In: Davidson JF, Rowan RM, Samama MM, Desnoyers PC (eds) Progress in chemical fibrinolysis and thrombolysis Vol III. Raven Press, New York, pp 65–75

    Google Scholar 

  7. 7.

    Castelan DJ, Hirsh J, Martin M (1968) Latex bound antifibrinogen test for plasma fibrinogen assay. J Clin Pathol 21: 638–642

    Google Scholar 

  8. 8.

    Collen D (1980) On the regulation and control of fibrinolysis. Thromb Haemost 43: 77–89

    Google Scholar 

  9. 9.

    Curd JG, Prograis LJ, Cochrane CG (1980) Detection of active kallikrein in induced blister fluid of hereditary angioedema patients. J Exp Med 152: 742–747

    Google Scholar 

  10. 10.

    Donaldson VH, Evans RR (1963) A biochemical abnormality in hereditary angioneurotic edema. Am J Med 35: 37–44

    Google Scholar 

  11. 11.

    Forbes CD, Pensky J, Ratnoff OD (1970) Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C'1 inhibitor. J Lab Clin Med 76: 809–815

    Google Scholar 

  12. 12.

    Frank MM, Gelfand JA, Atkinson JP (1976) Hereditary angioedema: The clinical syndrome and its management. Ann Int Med 84: 580–593

    Google Scholar 

  13. 13.

    Gelfand JA, Sherins RJ, Alling DW, Frank MM (1976) Treatment of hereditary angioneurotic edema with Danazol. New Engl J Med 295: 1444–1448

    Google Scholar 

  14. 14.

    Ghebrehiwet B, Silverberg M, Kaplan AP (1981) Activation of the classical pathway of complement by Hageman factor fragment. J Exp Med 153: 665–676

    Google Scholar 

  15. 15.

    Gigli I, Ruddy S, Austen KF (1968) The stoichiometric measurement of the serum inhibitor of the first component of complement by inhibition of immune hemolysis. J Immunol 100: 1154–1164

    Google Scholar 

  16. 16.

    Igarashi N, Matsumoto M, Takeuchi S, Asada T (1973) Assay method for fibrinolytic activity using affinity chromatography. J Med Technol 17: 713–722 (in Japanese)

    Google Scholar 

  17. 17.

    Inai S, Nagaki K, Ebisu S, Kato K, Kotani S, Misaki A (1976) Activation of the alternative complement pathway by water-soluble glucagons of streptococcus mutans: The relation between their chemical structures and activating potencies. J Immunol 117: 1256–1260

    Google Scholar 

  18. 18.

    Iwa M, Fujita S, Itoga T (1974) Studies upon the fibrinagar-plate method for measurement of fibrinolytic activity. Kyushu Ketsueki Kenkyu Dokokai Shi 24: 7–14 (in Japanese)

    Google Scholar 

  19. 19.

    Juhlin L, Michaelsson G (1969) Use of a kallikrein inhibitor in the treatment of urticaria and hereditary angioneurotic edema. Acta Derm Venereol 49: 37–44

    Google Scholar 

  20. 20.

    Klemperer MA, Donaldsen VH, Rosen FS (1968) Effect of C'1 esterase on vascular permeability in man: Studies in normal and complement deficient individuals and in patient with hereditary angioneurotic edema. J Clin Invest 47: 604–611

    Google Scholar 

  21. 21.

    Kopin IJ, Lake CR, Ziegler M (1978) Plasma level of norepinephrine. Ann Int Med 88: 671–680

    Google Scholar 

  22. 22.

    Landerman NS, Webster ME, Becker EL, Ratcliffe HE (1962) Hereditary angioneurotic edema II: Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein. J Allergy 33: 330–341

    Google Scholar 

  23. 23.

    Loskutoff DJ, Edgington TS (1977) Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. Proc Natl Acad Sci USA 74: 3903–3907

    Google Scholar 

  24. 24.

    Lundh B, Laurell AB, Wetterqvist H, White T, Granerus G (1968) A case of hereditary angioeurotic edema, successfully treated with ɛ-aminocaproic acid. Clin Exp Immunol 3: 733–745

    Google Scholar 

  25. 25.

    Mayer MM (1961) Complement and complement fixation. In: Charles C (ed) Experimental immunochemistry. Thomas Publishers, Springfield, pp 149–153

    Google Scholar 

  26. 26.

    Nagaki K, Iida K, Inai S (1974) A new method for the preparation of EC 14 cell with human or guinea-pig serum. J Immunol Meth 5: 307–317

    Google Scholar 

  27. 27.

    Ogston D, Bennett B (1978) Surface mediated reactions in the formation of thrombin, plasmin and kallikrein. Br Med Bull 34: 107–112

    Google Scholar 

  28. 28.

    Oh-ishi S, Katori M (1979) Fluorometric assay for plasma prekallikrein using peptidyl-methyl-coumarinyl-amide as substrate. Thromb Res 14: 551–559

    Google Scholar 

  29. 29.

    Oh-ishi S, Uchida A, Ueno A, Katori M (1979) Bromelein, a thioprotease from pineapple stem, depletes high molecular weight kininogen by activation of Hageman factor (Factor XII). Thromb Res 14: 665–672

    Google Scholar 

  30. 30.

    Proctor RR, Rapaport SI (1961) The partial thromboplastin time with kaolin. Am J Clin Pathol 36: 212–219

    Google Scholar 

  31. 31.

    Quick AM, Brown MS, Bancroft FW (1935) A study of the coagulation defect in hemophilia and in jaundice. AM J Med Sci 190: 501–511

    Google Scholar 

  32. 32.

    Ratnoff OD, Pensky J, Ogston D, Naff GB (1969) The inhibition of plasmin, plasma kallikrein, plasma permeability factor and C 1 r subcomponent of the first component of complement by serum C'1 esterase inhibitor. J Exp Med 129: 315–331

    Google Scholar 

  33. 33.

    Rosen FS, Alper CA, Pensky J, Klemperer MR, Donaldsen VH (1971) Genetically determined heterogeneity of the C 1-esterase inhibitor in patients with hereditary angioneurotic edema. J Clin Invest 50: 2143–2149

    Google Scholar 

  34. 34.

    Schapira M, Silver LD, Scott CF, Schaier AH, Prograis LJ, Curd JG, Colman RW (1983) Prekallikrein activation and high molecular weight kininogen consumption in hereditary angioedema. New Engl J Med 308: 1050–1053

    Google Scholar 

  35. 35.

    Schreiber AD, Kaplan AP, Austen KF (1973) Inhibition by C 1-INH of Hageman factor fragment activation of coagulation, fibrinolysis and kinin generation. J Clin Invest 52: 1402–1409

    Google Scholar 

  36. 36.

    Schultz KH (1974) Hereditäres Quincke-Ödem, neuere Wege der Therapie. Der Hautarzt 25: 12–16

    Google Scholar 

  37. 37.

    Uchida Y, Katori M (1978) An improved method for determination of the total kininogen in rabbit and human plasma. Biochem Pharmacol 27: 1463–1469

    Google Scholar 

  38. 38.

    Uchida Y, Katori M (1979) Differential assay method for high molecular weight and low molecular weight kininogen. Thromb Res 14: 127–134

    Google Scholar 

  39. 39.

    Wiggins RC, Loskutoff DJ, Cochrane C, Griffin JH (1980) Activation of rabbit Hageman factor by homogenate of cultured rabbit endothelial cells. J Clin Invest 65: 197–206

    Google Scholar 

  40. 40.

    Witzke G, Bork K, Benes P, Böckers M (1983) Hereditary angioneurotic edema and blood coagulation: Interaction between C 1-esterase-inhibitor and the activation factors of the proteolytic enzyme system. Klin Wochenschr 61: 1131–1135

    Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Junzo Kodama.

Additional information

Dedicated to Prof. emer. Dr. med. Tsuneo Yoshida on his 83rd birthday and to the late Prof. emer. Dr. med. Ernst Wollheim on his 80th birthday

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kodama, J., Uchida, K., Yoshimura, S. et al. Studies of four Japanese families with hereditary angioneurotic edema: Simultaneous activation of plasma protease systems and exogenous triggering stimuli. Blut 49, 405–418 (1984).

Download citation

Key words

  • Hereditary angioneurotic edema
  • Complement
  • Fibrinolysis
  • Coagulation
  • Kallikrein-kinin
  • Exogenous trigger